Order Article Reprints

Ueshima K, Nishida N, Hagiwara S, Minami Y, Ida H, Takita M, Chishina H, Morita M, Aoki T, Hamano T, et al. No Correlation Between Proteinuria and Renal Function in Patients with Unresectable Hepatocellular Carcinoma Treated with Atezolizumab Plus Bevacizumab: ARISE Study. Cancers. 2025; 17(23):3826. https://doi.org/10.3390/cancers17233826

Ueshima, Kazuomi, Naoshi Nishida, Satoru Hagiwara, Yasunori Minami, Hiroshi Ida, Masahiro Takita, Hirokazu Chishina, Masahiro Morita, Tomoko Aoki, Tetsutaro Hamano, and et al. 2025. "No Correlation Between Proteinuria and Renal Function in Patients with Unresectable Hepatocellular Carcinoma Treated with Atezolizumab Plus Bevacizumab: ARISE Study" Cancers 17, no. 23: 3826. https://doi.org/10.3390/cancers17233826

Ueshima, K., Nishida, N., Hagiwara, S., Minami, Y., Ida, H., Takita, M., Chishina, H., Morita, M., Aoki, T., Hamano, T., Take, R., Watanabe, C., Asoh, K., Tanaka, A., & Kudo, M. (2025). No Correlation Between Proteinuria and Renal Function in Patients with Unresectable Hepatocellular Carcinoma Treated with Atezolizumab Plus Bevacizumab: ARISE Study. Cancers, 17(23), 3826. https://doi.org/10.3390/cancers17233826